Here is the summary data through May 22, 2021.
Total reactions for the experimental mRNA vaccineTozinameran (code BNT162b2,Comirnaty) from BioNTech/ Pfizer: 5,961 deaths and 452,779 injuries to 22/05/2021
• 13,531 Blood and lymphatic system disorders incl. 59 deaths
• 9,828 Cardiac disorders incl. 735 deaths
• 71 Congenital, familial and genetic disorders incl. 4 deaths
• 5,468 Ear and labyrinth disorders incl. 3 deaths
• 183 Endocrine disorders
• 6,266 Eye disorders incl. 14 deaths
• 41,214 Gastrointestinal disorders incl. 216 deaths
• 128,031 General disorders and administration site conditions incl. 1,909 deaths
• 327 Hepatobiliary disorders incl. 27 deaths
• 4,802 Immune system disorders incl. 31 deaths
• 13,948 Infections and infestations incl. 648 deaths
• 4,821 Injury, poisoning and procedural complications incl. 81 deaths
• 10,374 Investigations incl. 221 deaths
• 3,354 Metabolism and nutrition disorders incl. 120 deaths
• 65,326 Musculoskeletal and connective tissue disorders incl. 71 deaths
• 250 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 15 deaths
• 81,748 Nervous system disorders incl. 616 deaths
• 279 Pregnancy, puerperium and perinatal conditions incl. 7 deaths
• 88 Product issues
• 7,978 Psychiatric disorders incl. 94 deaths
• 1,342 Renal and urinary disorders incl. 93 deaths
• 1,570 Reproductive system and breast disorders incl. 3 deaths
• 18,597 Respiratory, thoracic and mediastinal disorders incl. 697 deaths
• 21,101 Skin and subcutaneous tissue disorders incl. 53 deaths
• 663 Social circumstances incl. 9 deaths
• 160 Surgical and medical procedures incl. 10 deaths
• 11,459 Vascular disorders incl. 225 deaths
Total reactions for the experimental mRNA vaccine mRNA-1273(CX-024414) from Moderna: 3,365 deaths and 72,596 injuries to 22/05/2021
• 1,335 Blood and lymphatic system disorders incl. 22 deaths
• 2,045 Cardiac disorders incl. 370 deaths
• 12 Congenital, familial and genetic disorders incl. 2 deaths
• 718 Ear and labyrinth disorders
• 37 Endocrine disorders incl. 1 death
• 997 Eye disorders incl. 4 deaths
• 6,305 Gastrointestinal disorders incl. 108 deaths
• 20,774 General disorders and administration site conditions incl. 1,480 deaths
• 129 Hepatobiliary disorders incl. 8 deaths
• 691 Immune system disorders incl. 4 deaths
• 2,392 Infections and infestations incl. 183 deaths
• 1,292 Injury, poisoning and procedural complications incl. 63 deaths
• 1,743 Investigations incl. 77 deaths
• 816 Metabolism and nutrition disorders incl. 64 deaths
• 9,149 Musculoskeletal and connective tissue disorders incl. 62 deaths
• 77 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 11 deaths
• 12,314 Nervous system disorders incl. 339 deaths
• 83 Pregnancy, puerperium and perinatal conditions
• 11 Product issues
• 1,375 Psychiatric disorders incl. 51 deaths
• 468 Renal and urinary disorders incl. 40 deaths
• 175 Reproductive system and breast disorders incl. 1 death
• 3,513 Respiratory, thoracic and mediastinal disorders incl. 306 deaths
• 3,726 Skin and subcutaneous tissue disorders incl. 23 deaths
• 259 Social circumstances incl. 9 deaths
• 235 Surgical and medical procedures incl. 26 deaths
• 1,925 Vascular disorders
Total reactions for the experimental vaccine AZD1222/VAXZEVRIA (CHADOX1 NCOV-19) from Oxford/ AstraZeneca: 2,489 deaths and 655,534 injuries to 22/05/2021
• 7,200 Blood and lymphatic system disorders incl. 100 deaths
• 9,748 Cardiac disorders incl. 311 deaths
• 103 Congenital, familial and genetic disorders incl. 2 deaths
• 6,740 Ear and labyrinth disorders
• 217 Endocrine disorders incl. 2 deaths
• 10,591 Eye disorders incl. 8 deaths
• 69,826 Gastrointestinal disorders incl. 116 deaths
• 178,037 General disorders and administration site conditions incl. 685 deaths
• 396 Hepatobiliary disorders incl. 20 deaths
• 2,409 Immune system disorders incl. 9 deaths
• 13,832 Infections and infestations incl. 163 deaths
• 5,870 Injury, poisoning and procedural complications incl. 46 deaths
• 13,474 Investigations incl. 50 deaths
• 8,405 Metabolism and nutrition disorders incl. 35 deaths
• 104,075 Musculoskeletal and connective tissue disorders incl. 25 deaths
• 222 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 6 deaths
• 141,437 Nervous system disorders incl. 388 deaths
• 156 Pregnancy, puerperium and perinatal conditions incl. 3 deaths
• 76 Product issues
• 12,272 Psychiatric disorders incl. 21 deaths
• 2,264 Renal and urinary disorders incl. 20 deaths
• 3,327 Reproductive system and breast disorders
• 21,237 Respiratory, thoracic and mediastinal disorders incl. 278 deaths
• 29,750 Skin and subcutaneous tissue disorders incl. 14 deaths
• 582 Social circumstances incl. 4 deaths
• 498 Surgical and medical procedures incl. 15 deaths
• 12,790 Vascular disorders incl. 168 deaths
Total reactions for the experimental COVID-19 vaccine JANSSEN (AD26.COV2.S) from Johnson & Johnson: 369 deaths and 15,281 injuries to 22/05/2021
• 145 Blood and lymphatic system disorders incl. 10 deaths
• 264 Cardiac disorders incl. 34 deaths
• 8 Congenital, familial and genetic disorders
• 77 Ear and labyrinth disorders
• 5 Endocrine disorders incl. 1 death
• 191 Eye disorders incl. 2 deaths
• 1,302 Gastrointestinal disorders incl. 11 deaths
• 3,619 General disorders and administration site conditions incl. 97 deaths
• 38 Hepatobiliary disorders incl. 2 deaths
• 51 Immune system disorders
• 245 Infections and infestations incl. 8 deaths
• 209 Injury, poisoning and procedural complications incl. 6 deaths
• 1,134 Investigations incl. 23 deaths
• 104 Metabolism and nutrition disorders incl. 10 deaths
• 2,368 Musculoskeletal and connective tissue disorders incl. 12 deaths
• 12 Neoplasms benign, malignant and unspecified (incl cysts and polyps)
• 3,051 Nervous system disorders incl. 48 death
• 7 Pregnancy, puerperium and perinatal conditions
• 8 Product issues
• 181 Psychiatric disorders incl. 3 deaths
• 69 Renal and urinary disorders incl. 4 deaths
• 62 Reproductive system and breast disorders
• 637 Respiratory, thoracic and mediastinal disorders incl. 29 deaths
• 324 Skin and subcutaneous tissue disorders incl. 1 death
• 39 Social circumstances incl. 2 deaths
• 214 Surgical and medical procedures incl. 20 deaths
• 917 Vascular disorders incl. 46 deaths